These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31929697)

  • 21. Effects of Coenzyme Q10 Supplementation on Serum Values of Gamma-glutamyl transferase, Pseudocholinesterase, Bilirubin, Ferritin, and High-Sensitivity C-Reactive Protein in Women with Type 2 Diabetes.
    Gholami M; Rezvanfar MR; Delavar M; Abdollahi M; Khosrowbeygi A
    Exp Clin Endocrinol Diabetes; 2019 May; 127(5):311-319. PubMed ID: 29365333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of empagliflozin plus metformin on T2DM mice shows no higher amelioration for glucose and lipid metabolism than empagliflozin monotherapy.
    Wang Z; Zhou J; Lu M; Liang Y; Jiang Z; Chen K
    Life Sci; 2019 Sep; 232():116622. PubMed ID: 31271767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Metformin, Acarbose and Their Combination on the Serum Visfatin Level in Nicotinamide/Streptozocin-Induced Type 2 Diabetic Rats.
    Salemi Z; Rafie E; Goodarzi MT; Ghaffari MA
    Iran Red Crescent Med J; 2016 Mar; 18(3):e23814. PubMed ID: 27247792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
    Maheshwari RA; Balaraman R; Sen AK; Seth AK
    Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease.
    Kruszelnicka O; Chyrchel B; Golay A; Surdacki A
    Amino Acids; 2015 Sep; 47(9):1951-9. PubMed ID: 25859650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.
    Kadoglou NP; Tsanikidis H; Kapelouzou A; Vrabas I; Vitta I; Karayannacos PE; Liapis CD; Sailer N
    Metabolism; 2010 Mar; 59(3):373-9. PubMed ID: 19815243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved endothelial function with metformin in type 2 diabetes mellitus.
    Mather KJ; Verma S; Anderson TJ
    J Am Coll Cardiol; 2001 Apr; 37(5):1344-50. PubMed ID: 11300445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutaredoxin mediated redox effects of coenzyme Q10 treatment in type 1 and type 2 diabetes patients.
    Montano SJ; Grünler J; Nair D; Tekle M; Fernandes AP; Hua X; Holmgren A; Brismar K; Ungerstedt JS
    BBA Clin; 2015 Dec; 4():14-20. PubMed ID: 26966682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W
    J Clin Lipidol; 2018; 12(2):417-427.e5. PubMed ID: 29454678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of metformin and/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: Concepts and clinical practice.
    Al-Kuraishy HM; Al-Gareeb AI; Waheed HJ; Al-Maiahy TJ
    J Adv Pharm Technol Res; 2018; 9(3):80-86. PubMed ID: 30338233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of gliclazide add on metformin on serum omentin-1 levels in patients with type 2 diabetes mellitus.
    Al-Gareeb AI; Alrubai HF; Suliaman SM
    Indian J Endocrinol Metab; 2016; 20(2):195-8. PubMed ID: 27042415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
    Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
    Pharmacotherapy; 2013 Aug; 33(8):817-26. PubMed ID: 23744726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imbalanced low-grade inflammation and endothelial activation in patients with type 2 diabetes mellitus and erectile dysfunction.
    Araña Rosaínz Mde J; Ojeda MO; Acosta JR; Elías-Calles LC; González NO; Herrera OT; García Álvarez CT; Rodríguez EM; Báez ME; Seijas EÁ; Valdés RF
    J Sex Med; 2011 Jul; 8(7):2017-30. PubMed ID: 21554550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial.
    de Jager J; Kooy A; Schalkwijk C; van der Kolk J; Lehert P; Bets D; Wulffelé MG; Donker AJ; Stehouwer CD
    J Intern Med; 2014 Jan; 275(1):59-70. PubMed ID: 23981104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interdependencies among Selected Pro-Inflammatory Markers of Endothelial Dysfunction, C-Peptide, Anti-Inflammatory Interleukin-10 and Glucose Metabolism Disturbance in Obese Women.
    Janowska J; Chudek J; Olszanecka-Glinianowicz M; Semik-Grabarczyk E; Zahorska-Markiewicz B
    Int J Med Sci; 2016; 13(7):490-9. PubMed ID: 27429585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
    Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial.
    Zahedi H; Eghtesadi S; Seifirad S; Rezaee N; Shidfar F; Heydari I; Golestan B; Jazayeri S
    J Diabetes Metab Disord; 2014; 13():81. PubMed ID: 26413493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome.
    Izadi A; Ebrahimi S; Shirazi S; Taghizadeh S; Parizad M; Farzadi L; Gargari BP
    J Clin Endocrinol Metab; 2019 Feb; 104(2):319-327. PubMed ID: 30202998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.
    Yang HK; Lee SH; Shin J; Choi YH; Ahn YB; Lee BW; Rhee EJ; Min KW; Yoon KH
    Diabetes Metab J; 2019 Jun; 43(3):287-301. PubMed ID: 30604599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients.
    Fysekidis M; Cosson E; Takbou K; Sutton A; Charnaux N; Banu I; Vicaut E; Valensi P
    Microvasc Res; 2018 Mar; 116():6-14. PubMed ID: 28954218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.